What is the Healthy Eating Active Lifestyle (HEAL)-GYN program studying for gynecologic cancer?

The HEAL-GYN program is studying how an 8-week lifestyle medicine intervention affects patients with gynecologic cancer. Researchers aim to evaluate changes in participants' confidence, lifestyle habits, mental health, well-being, and biological markers. The study is sponsored by AdventHealth and focuses on improving health through exercise, nutrition, sleep, and stress management.

Who may be eligible for this gynecologic cancer clinical trial?

Eligible participants are female adults aged 18 or older with a diagnosis of gynecologic cancer. They must be current patients in the Central Florida area and have completed or be completing chemotherapy within the past 3 months. Participants must also be able to speak, read, and understand English. Please review eligibility criteria for more details.

Is there any cost to participate in this gynecologic cancer clinical trial?

Study-related care, including the program and all trial visits, is provided at no cost. However, personal travel and other expenses may vary and are not guaranteed to be covered. Participants should plan accordingly for any associated costs.

Actively Recruiting

Phase Not Applicable

Age: 18Years +

FEMALE

ID07121738

Study of an 8-Week Healthy Eating and Active Lifestyle Program for Women With Gynecologic Cancer

Led by AdventHealth · Updated on 2026-03-03

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of an 8-week Healthy Eating Active Lifestyle HEAL-GYN program designed for patients with gynecologic cancer. This telemedicine-based rehabilitation focuses on lifestyle changes including exercise, nutrition, sleep, social integration, stress management, and avoiding risk behaviors like smoking and alcohol. The study aims to assess impacts on participants confidence in managing their health, lifestyle habits, mental health, overall well-being, and biological markers. The HEAL-GYN program is led by a certified lifestyle medicine oncologist and involves personalized goal-setting and practical instruction on healthy living. Up to 64 participants will engage in this behavioral intervention conducted remotely. The program includes regular monitoring through surveys and wearable activity trackers to measure physical activity and sleep. Participants will complete surveys at the start, end of the 8-week program, and at 1-month and 3-month follow-ups. These surveys use validated tools to assess lifestyle factors, mental health, and quality of life. Home health visits will collect biometric data and blood samples to analyze lab values and biomarkers such as adiponectin, insulin sensitivity, and inflammatory markers. This comprehensive monitoring supports evaluation of the programs effects over time.

CONDITIONS

Brief Title

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

How This Trial Compares With Other Options

This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.

Factors	Lifestyle Medicine Program (HEAL)	Usual Survivorship Care (No Structured Lifestyle Program)
What is it?	A structured, evidence-based lifestyle medicine survivorship program designed for adults who have completed chemotherapy for gynecologic cancer. It includes modules addressing nutrition, physical activity, sleep, stress management, weight management, and body image.	Routine post-chemotherapy oncology survivorship care, consisting of scheduled medical follow-up visits and ongoing symptom monitoring, without a dedicated structured lifestyle medicine program.
Role in study	Investigational intervention: All participants receive the full HEAL program during the study period.	Not studied in this trial; represents the standard care pathway typically received outside the context of a structured program.
Main purpose	To support healthy behavior changes, weight management, physical activity, sleep quality, and psychological wellbeing during gynecologic cancer survivorship.	To provide ongoing monitoring for cancer recurrence, late effects of treatment, and general health maintenance.
How is it delivered?	Delivered as a behavioral program with structured modules over set weeks, actively engaging participants in education and activities related to nutrition, exercise, sleep, stress, and health monitoring.	Standard survivorship involves routine care appointments and symptom review by oncologists or healthcare team, without a structured program for behavior change.
Evidence status	Currently under clinical investigation in this specified survivor population; published literature suggests benefits of lifestyle interventions in overall health and wellbeing for cancer survivors, but direct benefit for this specific program in gynecologic cancer is not yet established.	Routine survivorship care is established as standard practice but does not offer structured behavioral modification or lifestyle medicine programming; does not proactively address all survivorship challenges.
Important limitations	As a single-group trial, results may be affected by selection bias and lack a direct control group; program structure and intensity may also limit scalability outside the clinical setting.	Does not systematically address lifestyle, weight, activity, or psychological wellbeing; survivorship needs beyond recurrence monitoring may be unmet.

Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.

Who Can Participate

Age: 18Years +

FEMALE

Eligibility Criteria

You may qualify if you...

Adult 18 years old or over
Diagnosis of gynecologic cancer
Current patient in the Central Florida area
Completing or have completed chemotherapy treatment within approximately the past 3 months before starting the program
Able to speak, read, and understand the English language.

You will not qualify if you...

Not willing or able to provide informed consent
Not willing or able to comply with all study procedures and requirement for the duration of the study

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility assessment

Outpatient Treatment

Duration - 8 weeks

Participants undergo an 8-week telemedicine-based lifestyle medicine program focusing on exercise, nutrition, sleep, social integration, stress management, and avoidance of risk behaviors with personalized goal-setting and instruction.

Weekly remote visits for up to 8 weeks

Follow-up

Duration - 3 months

Participants complete follow-up assessments including surveys and biometric measurements to evaluate lifestyle factors, mental health, and biomarkers at 1 month and 3 months after the intervention ends.

3 visits including 1-month and 3-month follow-up assessments